BioCatalystWatch
VTVTWorkspace / VTVT / OverviewCompany library
vTv Therapeutics Inc. logo

vTv Therapeutics Inc.

vTv Therapeutics Inc. (VTVT)

Website

Price
Market cap
Next catalystExpected 2H 2027Cadisegliatin — Middle East Phase 2 with G42 · Trial initiationSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

Cadisegliatin

Glucokinase (GK)

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Cadisegliatin

Glucokinase (GK)

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Other pipelines

Cadisegliatin

Glucokinase (GK)

PreINDP1P2P3FilingApproved
HPP3033

Nrf2 × Bach1

PreINDP1P2P3FilingApproved

Partner / License out

Cadisegliatin

Glucokinase (GK)

PreINDP1P3FilingApproved
Upcoming / outlook

RAGE

Bach1

PreINDP1P2P3FilingApproved

Bach1

PreINDP1P2P3FilingApproved

History / paused

RAGE

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Market Reaction / Supply Context

Market Structure

VTVT PR & News

VTVT SEC archive